As the leading cause of cancer-related deaths worldwide, although many pathological molecular mechanisms related to lung cancer, especially NSCLC, have been discovered and successful immunotherapies against PD-1 have been developed, there are still many NSCLC patients who cannot benefit from them. Here, PDCD1 is linked to non-small cell lung carcinoma.